New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know?
Publication
, Journal Article
Pagidipati, NJ; Lopes, RD
Published in: J Thorac Cardiovasc Surg
October 2019
Duke Scholars
Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
October 2019
Volume
158
Issue
4
Start / End Page
1113 / 1117
Location
United States
Related Subject Headings
- Treatment Outcome
- Sodium-Glucose Transporter 2 Inhibitors
- Risk Factors
- Risk Assessment
- Respiratory System
- Patient Selection
- Incretins
- Humans
- Glucagon-Like Peptide-1 Receptor
- Diabetes Mellitus, Type 2
Citation
APA
Chicago
ICMJE
MLA
NLM
Pagidipati, N. J., & Lopes, R. D. (2019). New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know? J Thorac Cardiovasc Surg, 158(4), 1113–1117. https://doi.org/10.1016/j.jtcvs.2019.03.140
Pagidipati, Neha J., and Renato D. Lopes. “New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know?” J Thorac Cardiovasc Surg 158, no. 4 (October 2019): 1113–17. https://doi.org/10.1016/j.jtcvs.2019.03.140.
Pagidipati NJ, Lopes RD. New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know? J Thorac Cardiovasc Surg. 2019 Oct;158(4):1113–7.
Pagidipati, Neha J., and Renato D. Lopes. “New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know?” J Thorac Cardiovasc Surg, vol. 158, no. 4, Oct. 2019, pp. 1113–17. Pubmed, doi:10.1016/j.jtcvs.2019.03.140.
Pagidipati NJ, Lopes RD. New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know? J Thorac Cardiovasc Surg. 2019 Oct;158(4):1113–1117.
Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
October 2019
Volume
158
Issue
4
Start / End Page
1113 / 1117
Location
United States
Related Subject Headings
- Treatment Outcome
- Sodium-Glucose Transporter 2 Inhibitors
- Risk Factors
- Risk Assessment
- Respiratory System
- Patient Selection
- Incretins
- Humans
- Glucagon-Like Peptide-1 Receptor
- Diabetes Mellitus, Type 2